Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.
2.

Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk.

Corsetti JP, Bakker SJL, Gansevoort RT, Gruppen EG, Connelly MA, Sparks CE, Dullaart RPF.

Int J Mol Sci. 2019 Feb 23;20(4). pii: E977. doi: 10.3390/ijms20040977.

3.

Insulin resistance involvement in prevalence of familial dysbetalipoproteinemia in ε2ε2 subjects by Bayesian network modeling.

Corsetti JP, Love TM, Sparks CE, Bakker SJL, Dullaart RPF.

Clin Biochem. 2018 Sep;59:31-36. doi: 10.1016/j.clinbiochem.2018.06.009. Epub 2018 Jun 18.

PMID:
29928902
4.

Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.

Corsetti JP, Sparks CE, Bakker SJL, Gruppen EG, Dullaart RPF.

Clin Biochem. 2018 Feb;52:67-72. doi: 10.1016/j.clinbiochem.2017.11.010. Epub 2017 Nov 20.

PMID:
29157655
5.

Autophagy and hepatic steatosis.

Sparks CE, Sparks JD.

Curr Opin Lipidol. 2017 Aug;28(4):383-384. doi: 10.1097/MOL.0000000000000436. Review. No abstract available.

PMID:
28700380
6.

Inflammatory markers modify the risk of recurrent coronary events associated with apolipoprotein A-I in postinfarction patients.

Wang M, Corsetti J, McNitt S, Rich DQ, Sparks CE, Moss AJ, Zareba W.

J Clin Lipidol. 2017 Jan - Feb;11(1):215-223. doi: 10.1016/j.jacl.2016.12.008. Epub 2016 Dec 28.

7.

Phosphatidylinositol (3,4,5)-trisphosphate binds to sortilin and competes with neurotensin: Implications for very low density lipoprotein binding.

Sparks RP, Jenkins JL, Miner GE, Wang Y, Guida WC, Sparks CE, Fratti RA, Sparks JD.

Biochem Biophys Res Commun. 2016 Oct 21;479(3):551-556. doi: 10.1016/j.bbrc.2016.09.108. Epub 2016 Sep 22.

8.

Sortilin facilitates VLDL-B100 secretion by insulin sensitive McArdle RH7777 cells.

Sparks RP, Guida WC, Sowden MP, Jenkins JL, Starr ML, Fratti RA, Sparks CE, Sparks JD.

Biochem Biophys Res Commun. 2016 Sep 16;478(2):546-52. doi: 10.1016/j.bbrc.2016.07.096. Epub 2016 Aug 2.

9.
10.

Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation.

Corsetti JP, Salzman P, Ryan D, Moss AJ, Zareba W, Sparks CE.

Atherosclerosis. 2016 Jul;250:1-8. doi: 10.1016/j.atherosclerosis.2016.04.017. Epub 2016 Apr 21.

PMID:
27174532
11.

The enigmatic role of sortilin in lipoprotein metabolism.

Sparks CE, Sparks RP, Sparks JD.

Curr Opin Lipidol. 2015 Dec;26(6):598-600. doi: 10.1097/MOL.0000000000000244. No abstract available.

12.

Insulin dependent apolipoprotein B degradation and phosphatidylinositide 3-kinase activation with microsomal translocation are restored in McArdle RH7777 cells following serum deprivation.

Sparks JD, Magra AL, Chamberlain JM, O'Dell C, Sparks CE.

Biochem Biophys Res Commun. 2016 Jan 8;469(2):326-31. doi: 10.1016/j.bbrc.2015.11.068. Epub 2015 Nov 23.

13.

Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants.

Corsetti JP, Gansevoort RT, Bakker SJ, Sparks CE, Vart P, Dullaart RP.

J Am Soc Nephrol. 2014 Dec;25(12):2906-15. doi: 10.1681/ASN.2013121256. Epub 2014 May 22.

14.

High-density lipoproteins: taking the good with the bad.

Sparks CE, Corsetti JP, Sparks JD.

Curr Opin Lipidol. 2014 Jun;25(3):230-2. doi: 10.1097/MOL.0000000000000079. No abstract available.

PMID:
24763089
15.

Hepatic postprandial transition and very low-density lipoprotein biogenesis.

Sparks CE, Sparks JD.

Curr Opin Lipidol. 2013 Oct;24(5):450-2. doi: 10.1097/MOL.0b013e3283654ed0. No abstract available.

PMID:
24005219
16.

Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels.

Corsetti JP, Salzman P, Ryan D, Moss AJ, Zareba W, Sparks CE.

PLoS One. 2013 Jul 9;8(7):e68920. doi: 10.1371/journal.pone.0068920. Print 2013.

17.

Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases.

Sparks JD, O'Dell C, Chamberlain JM, Sparks CE.

Biochem Biophys Res Commun. 2013 Jun 14;435(4):616-20. doi: 10.1016/j.bbrc.2013.05.029. Epub 2013 May 15.

18.

Insulin suppression of apolipoprotein B in McArdle RH7777 cells involves increased sortilin 1 interaction and lysosomal targeting.

Chamberlain JM, O'Dell C, Sparks CE, Sparks JD.

Biochem Biophys Res Commun. 2013 Jan 4;430(1):66-71. doi: 10.1016/j.bbrc.2012.11.022. Epub 2012 Nov 15.

19.

Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation.

Le NT, Corsetti JP, Dehoff-Sparks JL, Sparks CE, Fujiwara K, Abe J.

Int J Inflam. 2012;2012:678190. Epub 2012 Sep 6.

20.

Hepatic steatosis and VLDL hypersecretion.

Sparks CE, Sparks JD.

Curr Opin Lipidol. 2012 Aug;23(4):395-7. doi: 10.1097/MOL.0b013e3283555afa. No abstract available.

PMID:
22801389

Supplemental Content

Loading ...
Support Center